Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

Clinical trial NCT06220214 · RECRUITING

Trial details

NCT number: NCT06220214
Sponsor: Alison Stopeck
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Locally Advanced Breast Cancer Neoadjuvant Chemotherapy HER2-positive Breast Cancer Triple Negative Breast Cancer TNBC, Triple Negative Breast Cancer

Start date: 2024-03-06
Primary completion: 2026-07-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.